Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1671.24 | 1445 / 1445 | 100% | 56.39 | 183 / 183 |
lung | 100% | 1872.66 | 578 / 578 | 100% | 49.43 | 1155 / 1155 |
ovary | 100% | 1456.27 | 180 / 180 | 100% | 31.77 | 430 / 430 |
uterus | 100% | 1708.22 | 170 / 170 | 100% | 48.49 | 459 / 459 |
breast | 100% | 2019.80 | 459 / 459 | 100% | 45.91 | 1117 / 1118 |
intestine | 100% | 1920.96 | 966 / 966 | 99% | 41.25 | 524 / 527 |
bladder | 100% | 1646.76 | 21 / 21 | 99% | 42.64 | 500 / 504 |
thymus | 100% | 1998.76 | 653 / 653 | 99% | 34.47 | 600 / 605 |
brain | 99% | 890.43 | 2623 / 2642 | 100% | 47.32 | 704 / 705 |
prostate | 100% | 1385.36 | 245 / 245 | 99% | 27.92 | 497 / 502 |
stomach | 100% | 1509.23 | 359 / 359 | 99% | 38.83 | 283 / 286 |
kidney | 100% | 1356.45 | 89 / 89 | 98% | 38.98 | 887 / 901 |
pancreas | 99% | 1312.41 | 325 / 328 | 99% | 34.98 | 176 / 178 |
skin | 100% | 2447.05 | 1807 / 1809 | 96% | 42.49 | 455 / 472 |
liver | 100% | 1240.78 | 226 / 226 | 95% | 18.92 | 386 / 406 |
adrenal gland | 100% | 2235.11 | 258 / 258 | 94% | 22.47 | 216 / 230 |
adipose | 100% | 2268.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.11 | 29 / 29 |
spleen | 100% | 1967.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.53 | 1 / 1 |
blood vessel | 100% | 1762.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 798.18 | 786 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 734.50 | 835 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 1745.09 | 748 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 14.66 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904294 | Biological process | positive regulation of ERAD pathway |
GO_0010868 | Biological process | negative regulation of triglyceride biosynthetic process |
GO_0090331 | Biological process | negative regulation of platelet aggregation |
GO_0051924 | Biological process | regulation of calcium ion transport |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0044233 | Cellular component | mitochondria-associated endoplasmic reticulum membrane contact site |
GO_0005576 | Cellular component | extracellular region |
GO_0012505 | Cellular component | endomembrane system |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015036 | Molecular function | disulfide oxidoreductase activity |
GO_0015035 | Molecular function | protein-disulfide reductase activity |
GO_0003756 | Molecular function | protein disulfide isomerase activity |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TMX1 |
Protein name | Thioredoxin related transmembrane protein 1 Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein) |
Synonyms | PSEC0085 TMX TXNDC UNQ235/PRO268 TXNDC1 |
Description | FUNCTION: Thiredoxin domain-containing protein that participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions . Acts as a key inhibitor of the alternative triglyceride biosynthesis pathway by inhibiting the activity of TMEM68/DIESL at the endoplasmic reticulum, thereby restricting accumulation of triacylglycerol . The alternative triglyceride biosynthesis pathway mediates formation of triacylglycerol from diacylglycerol and membrane phospholipids . Acts as a protein disulfide isomerase by catalyzing formation or reduction of disulfide bonds . Specifically mediates formation of disulfide bonds of transmembrane proteins at the endoplasmic reticulum membrane . Involved in endoplasmic reticulum-associated degradation (ERAD) via its protein disulfide isomerase activity by acting on folding-defective polypeptides at the endoplasmic reticulum membrane . Acts as a negative regulator of platelet aggregation following secretion in the extracellular space . Acts as a regulator of endoplasmic reticulum-mitochondria contact sites via its ability to regulate redox signals . Regulates endoplasmic reticulum-mitochondria Ca(2+) flux . . |
Accessions | ENST00000457354.7 G3V448 ENST00000556683.1 Q9H3N1 |